300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Seychelles
Moldova
Paraguay
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Asia
Bermuda
Dominican Republic
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Redhill Capital, VC Fund

Redhill Capital

VC Fund

Guangzhou, China

Redhill Capital is a venture capital firm specializing in early stage investment. It primary invests in medical industry.

Total investments:
33
Last investment:
Lead investor:
58%
Last fund:

Last updated:

Industries Redhill Capital invests in

Health CareBiotechnologyMedicalBiopharmaMedical Device

Stages Redhill Capital invests in

SeedAngelSeries AVenture - Series UnknownSeries B

Countries Redhill Capital invests in

China

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Health Care 10 (30%)
  • Biotechnology 8 (24%)
  • Medical 7 (21%)
  • Biopharma 4 (12%)
  • Medical Device 4 (12%)
See all 30 industries →

Stage

  • Seed 9 (27%)
  • Angel 6 (18%)
  • Series A 6 (18%)
  • Venture - Series Unknown 5 (15%)
  • Series B 3 (9%)
See all 7 stages →

Team

NameTitleInvestmentsLinksEmail
Frank Su
Frank Su Founding Partner
Founding Partner Total investments: 0 Find email
Cherry Lu
Cherry Lu Founding and Managing Partner
Founding and Managing Partner Total investments: 0
Find email
Dr. Li Jie Managing Director
Managing Director Total investments: 5 Find email
Lu Qinchao
Lu Qinchao Redhill Capital is a venture capital firm focusing on the medical industry.
Redhill Capital is a venture capital firm focusing on the medical industry. Total investments: 5
Find email

Investments

CompanyDescriptionRoundLinks
Creatulize Creatulize
Creatulize is a technology company specializing in the field of intelligent robots. Angel / Feb 11, 2026
Xintu Intelligent Sense
Xintu Intelligent Sensor is a design company dedicated to high-performance sensor chips. Focused on intelligent sensing chips and edge-to-edge intelligent products integrating multi-dimensional sensing and AI. Series A / Aug 06, 2025
Guangna Development Guangna Development
Guangna Siwei is an optoelectronic device seller. Seed / Mar 03, 2025
Inflamax Pharmaceuticals Inflamax Pharmaceuticals
Inflamax Pharmaceuticals is a biomedical technology company that specializes in the innovation and development of immune-inflammatory drugs. Angel / Oct 20, 2023
Douli Douli
Douli is an employee service platform that provides welfare solutions for enterprises. They offer services in the fields of clothing, food, housing, transportation, medical care, entertainment, and more by combining online and offline multi-channel resources. Venture - Series Unknown / Aug 08, 2023
EnCureGen Pharmaceuticals EnCureGen Pharmaceuticals
Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases. Seed / Jun 08, 2023
Xianwei Medical Xianwei Medical
Xianwei Medical is a manufacturer of ophthalmic surgical robots. It focuses on the field of ophthalmic surgical robots, promoting the product finalization and inspection of the third-generation ophthalmic surgical robots while also starting the medical treatment of other product pipelines under research, such as dry eye treatment equipment. Angel / May 17, 2023
ZD Medtech ZD Medtech
Zhuo Dao Medical has a domestic R&D team of rehabilitation robots dedicated to providing world-leading robotic assistive technology and intelligent rehabilitation solutions for clinical rehabilitation. With rich training mode, excellent human-computer interaction and intelligent rehabilitation management system, Zhuo Dao Medical is adapting tothe needs of Chinese rehabilitation medicine through continuous accumulation and continuous innovation in the field of rehabilitation engineering, and promoting the rapid development of rehabilitation medicine. . $14.6M / Series B / Feb 15, 2023
ExoNeuglia ExoNeuglia
ExoNeuglia is a biotech company that specializes in the development of cell drugs through the induced reprogramming pathway and therapies for nervous system diseases. Seed / Dec 08, 2022
Huawei Hengyuan Huawei Hengyuan
Huawei Hengyuan is a biomedical technology company dedicated to the preparation of Sertoli cells (with immune immunity) in vitro using cell reprogramming technology, mainly for: autoimmune diseases (such as rheumatoid arthritis); reproductive adjuvant therapy; human body Chronic diseases (such as Parkinson's); organ/tissue colonization(such as skin allograft). Seed / Dec 05, 2022
See all 33 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Seychelles
Moldova
Paraguay
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Asia
Bermuda
Dominican Republic
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Redhill Capital invest in?

Redhill Capital invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Angel stage. Most of the 33 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Redhill Capital?

Public channels for Redhill Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Redhill Capital?

The team at Redhill Capital includes Frank Su (Founding Partner), Cherry Lu (Founding and Managing Partner) and Dr. Li Jie (Managing Director). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Redhill Capital Redhill Capital Find emails